INTERNATIONAL PATENT: SHANGHAI PUBLIC HEALTH CLINICAL CENTER, 上海市公共卫生临床中心 FILES APPLICATION FOR "USE OF H1.2 AS TARGET IN PREPARATION OF DRUG FOR ENHANCING ANTIVIRAL IMMUNITY AND ANTIVIRAL INFECTION"

GENEVA, Feb. 2 -- SHANGHAI PUBLIC HEALTH CLINICAL CENTER (2901 Caolang RoadJinshan District, Shanghai 201599), 上海市公共卫生临床中心 (中国上海市金山区漕廊公路2901号) filed a patent application (PCT/CN2025/120656) for "USE OF H1.2 AS TARGET IN PREPARATION OF DRUG FOR ENHANCING ANTIVIRAL IMMUNITY AND ANTIVIRAL INFECTION" on Sep 11, 2025. With publication no. WO/2026/021615, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Pro...